Ross Stores Announces Fourth Quarter and Fiscal 2017 Earnings Release and Conference Call
Feb 20, 2018 13:30 pm UTC| Business
Dublin, CA, Feb. 20, 2018 -- Ross Stores, Inc. (Nasdaq: ROST) will announce its fourth quarter and fiscal 2017 earnings results on Tuesday, March 6, 2018. A press release will be sent out at approximately 4:00 p.m....
WisdomTree ETFs Declare Distributions
Feb 20, 2018 13:30 pm UTC| Business
NEW YORK, Feb. 20, 2018 -- WisdomTree (NASDAQ:WETF) today announced that WisdomTree declared distributions for the following WisdomTree ETFs. Rates are listed below: TickerFund NameEx-dateRecord DatePay DateOrdinary...
Nuvectra Secures $45 Million Second Amendment to Existing Loan and Security Agreement
Feb 20, 2018 13:30 pm UTC| Business
PLANO, Texas, Feb. 20, 2018 -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it has reached an agreement with Silicon Valley Bank and Oxford Finance, the lenders of...
Acology’s Perfect Package: MedTainer Confirmed Compliant for US, Canada and Mexico
Feb 20, 2018 13:30 pm UTC| Business
CORONA, Calif, Feb. 20, 2018 -- Acology Inc. (OTCMARKETS:ACOL) confirmed today that its signature product, the MedTainer™, is compliant for the entire North American market, and specifically for the growing Canadian...
Histogenics Corporation to Present at Upcoming Investor Conferences
Feb 20, 2018 13:30 pm UTC| Business
WALTHAM, Mass., Feb. 20, 2018 -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, announced...
Marrone Bio Innovations Announces The Netherlands as New Rapporteur Member State for Sakalia
Feb 20, 2018 13:30 pm UTC| Business
DAVIS, Calif., Feb. 20, 2018 -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and water treatment...
Onconova Announces Two Presentations at 2018 American Chemical Society National Meeting and Expo
Feb 20, 2018 13:30 pm UTC| Business
Product stability studies for rigosertib, a Phase 3 clinical stage product in development for Myelodysplastic Syndromes (MDS)Discovery of a novel kinase inhibitor, ON 150030, a Type 1 inhibitor of FLT3 and Src for relapsed...